546 related articles for article (PubMed ID: 30873179)
1. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
Vilgelm AE; Richmond A
Front Immunol; 2019; 10():333. PubMed ID: 30873179
[TBL] [Abstract][Full Text] [Related]
2. Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations.
Guan M; Liu S; Yang YG; Song Y; Zhang Y; Sun T
Int J Biol Macromol; 2024 May; 268(Pt 1):131679. PubMed ID: 38641274
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of chemokines in small cell lung cancer: Road signs for metastasis, heterogeneity, and immune response.
Khan P; Fatima M; Khan MA; Batra SK; Nasser MW
Semin Cancer Biol; 2022 Dec; 87():117-126. PubMed ID: 36371025
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
[TBL] [Abstract][Full Text] [Related]
5. The functional roles of chemokines and chemokine receptors in colorectal cancer progression.
Yue M; Chen MM; Zhang B; Wang Y; Li P; Zhao Y
Biomed Pharmacother; 2024 Jan; 170():116040. PubMed ID: 38113624
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.
Jin J; Zhao Q
Theranostics; 2020; 10(14):6231-6244. PubMed ID: 32483450
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
[TBL] [Abstract][Full Text] [Related]
8. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
[TBL] [Abstract][Full Text] [Related]
9. Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.
Salazar N; Castellan M; Shirodkar SS; Lokeshwar BL
Crit Rev Eukaryot Gene Expr; 2013; 23(1):77-91. PubMed ID: 23557339
[TBL] [Abstract][Full Text] [Related]
10. Atypical chemokine receptors: emerging therapeutic targets in cancer.
Torphy RJ; Yee EJ; Schulick RD; Zhu Y
Trends Pharmacol Sci; 2022 Dec; 43(12):1085-1097. PubMed ID: 36307250
[TBL] [Abstract][Full Text] [Related]
11. Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors.
Zhang Y; Guan XY; Jiang P
Front Immunol; 2020; 11():594609. PubMed ID: 33381115
[TBL] [Abstract][Full Text] [Related]
12. Immune cell promotion of metastasis.
Kitamura T; Qian BZ; Pollard JW
Nat Rev Immunol; 2015 Feb; 15(2):73-86. PubMed ID: 25614318
[TBL] [Abstract][Full Text] [Related]
13. Chemokines network in bone metastasis: Vital regulators of seeding and soiling.
Sharma G; Pothuraju R; Kanchan RK; Batra SK; Siddiqui JA
Semin Cancer Biol; 2022 Nov; 86(Pt 3):457-472. PubMed ID: 35124194
[TBL] [Abstract][Full Text] [Related]
14. Physiology of chemokines in the cancer microenvironment.
Drouillard D; Craig BT; Dwinell MB
Am J Physiol Cell Physiol; 2023 Jan; 324(1):C167-C182. PubMed ID: 36317799
[TBL] [Abstract][Full Text] [Related]
15. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy.
Giacobbi NS; Mullapudi S; Nabors H; Pyeon D
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400076
[TBL] [Abstract][Full Text] [Related]
16. Immunological nanomaterials to combat cancer metastasis.
Pan Y; Cheng J; Zhu Y; Zhang J; Fan W; Chen X
Chem Soc Rev; 2024 Jun; 53(12):6399-6444. PubMed ID: 38745455
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in tumor progression and metastasis.
Tanaka T; Bai Z; Srinoulprasert Y; Yang BG; Hayasaka H; Miyasaka M
Cancer Sci; 2005 Jun; 96(6):317-22. PubMed ID: 15958053
[TBL] [Abstract][Full Text] [Related]
18. Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications.
Maurya SK; Khan P; Rehman AU; Kanchan RK; Perumal N; Mahapatra S; Chand HS; Santamaria-Barria JA; Batra SK; Nasser MW
Semin Cancer Biol; 2022 Nov; 86(Pt 3):914-930. PubMed ID: 34968667
[TBL] [Abstract][Full Text] [Related]
19. Role of chemokine systems in cancer and inflammatory diseases.
Li H; Wu M; Zhao X
MedComm (2020); 2022 Jun; 3(2):e147. PubMed ID: 35702353
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer.
Kitamura T; Pollard JW
Pharmacol Res; 2015 Oct; 100():266-70. PubMed ID: 26275794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
